Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
MediPoint: Digit Replacement - Europe Analysis and Market Forecasts
Publication Date Mar 2017
Product Type Report
Pages 31
Single User License help $ 5000.00
Site User License help $ 10000.00
Corporate User License help $ 15000.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

Digit replacement is an intervention indicated for dysfunction of the finger joint due to trauma or arthritis. It is a substitute to arthrodesis when joint pain begins to interfere with daily activities and other medical management routes fail to provide relief. The procedure is complicated and there is a steep learning curve to competency as low procedure numbers prevent surgeons from getting enough hands-on experience. The goal of digit arthroplasty is to relieve pain, fix deformities and maintain the function and appearance of the fingers. Compared to other arthroplasties, the market share of digit replacement is paltry and therefore its addition to a company’s portfolio is normally a strategic business decision.

This report focuses on the market outlook for digit replacement devices in Europe (Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey, and UK). The analysis identifies the key unmet needs in the digit replacement market, discusses the major drivers and barriers of adoption, and provides an in-depth understanding of physicians’ perceptions and the future outlook for this market by segment and geography.

Key Questions Answered

What is the current and future digit replacement market outlook in the developed and emerging markets? What trends are affecting the global market?

Which are the key, high growth markets that digit replacement manufacturers should expand into?

What are the unmet needs with the current generation of digit replacement devices? How will emerging technologies fulfill these unmet needs?

What are the challenges and complications that have hindered widespread adoption?

With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the digit replacement market?

Scope

Overview of recent key industry events and analysis of their market impact.

Annualized total market revenue, procedure trends, and market outlooks by segment and by region through 2023.

Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies in the market.

Analysis of the current and future market competition in the global digit replacement market. Insightful review of industry drivers, barriers, and challenges.

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

2.1 Key Metrics

2.2 Market Dynamics

2.3 Key Players

2.4 Future Outlook

2.5 What Do Physicians Think?

3 Introduction

3.1 Catalyst

3.2 Related Reports

3.3 Upcoming Related Reports

4 Market Outlook

4.1 Procedure Trends

4.2 Pricing Trends

4.3 Revenue Trends

4.4 Company Share Analysis

5 Market Insights

5.1 Europe

5.1.1 Denmark, Finland, Norway, and Sweden

5.1.2 Belgium, France, and Netherlands

5.1.3 Germany and Switzerland

5.1.4 UK and Ireland

5.1.5 Italy, Portugal, and Spain

5.1.6 Austria, Czech Republic, Hungary, and Poland

5.1.7 Russia, Turkey, and Greece

6 Competitive Assessment

6.1 Overview

6.2 Integra LifeSciences

6.2.1 Portfolio Assessment

6.2.2 Deal Analysis

6.2.3 Competitive Positioning

6.3 Stryker

6.3.1 Portfolio Assessment

6.3.2 Deal Analysis

6.3.3 Competitive Positioning

6.4 Wright Medical

6.4.1 Portfolio Assessment

6.4.2 Deal Analysis

6.4.3 Competitive Positioning

6.5 Zimmer Biomet

6.5.1 Portfolio Assessment

6.5.2 Deal Analysis

6.5.3 Competitive Positioning

6.6 Depuy Orthopaedics

6.6.1 Portfolio Assessment

6.6.2 Deal Analysis

6.6.3 Competitive Positioning

6.7 Other Players

7 Appendix

7.1 Bibliography

7.2 Abbreviations

7.3 Methodology

7.3.1 Overview

7.3.2 Coverage

7.3.3 Secondary Research

7.3.4 Forecasting Methodology

7.3.5 Primary Research Summary

7.4 About the Authors

7.4.1 Analyst

7.4.2 Global Head of Medical Devices

7.5 About MediPoint

7.6 About GlobalData

7.7 Contact Us

7.8 Disclaimer


List of tables

Table 1: Key Metrics in the European Markets

Table 2: Europe Procedure Volume Forecast, 2014–2023

Table 3: Europe Average Selling Price Forecast, 2014–2023

Table 4: Europe Sales Forecast ($M), 2014–2023

Table 5: Europe Company Share Analysis, 2016

Table 6: Integra LifeSciences – Key Marketed Products Assessment

Table 7: Integra LifeSciences – Key Clinical Trials

Table 8: Stryker – Key Marketed Products Assessment

Table 9: Wright Medical – Key Marketed Products Assessment

Table 10: Zimmer Biomet Medical – Key Marketed Products Assessment

Table 11: Depuy Orthopaedics Medical – Key Marketed Products Assessment

Table 12: Summary of Other Players in the Market, 2017


List of figures

Figure 1: Europe Sales for Digit Replacement by Country, 2016 and 2023

Title Date Price
Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report
By QYResearch
The Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Digital Camera Head for Endoscopes industry. The re ...Read More
Apr 2016 $3600.00
Global Dental Laboratory Handpieces Consumption 2016 Market Research Report
By QYResearch
The Global Dental Laboratory Handpieces Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Dental Laboratory Handpieces market. First, the report ...Read More
Jan 2016 $4000.00
Back to Report Store Home Cardiovascular Disorders Drug Development Pipeline Review, 2017
By GBI Research
Description Cardiovascular disease (CVD) covers a range of difference diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dys ...Read More
Mar 2017 $3995.00
Back to Report Store Home Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes
By GBI Research
Pain, and in particular chronic pain, is a significant global health issue. While pain is not considered a disease in its own right, there is a growing body of evidence that substantiates chronic pain ...Read More
Aug 2016 $6995.00
Back to Report Store Home Frontier Pharma: Dermatology - Intracellular Signal Transducers and Cytokine Signaling Molecules Dominate Pipeline and First-in-Class Innovation
By GBI Research
Description Dermatology is a highly diverse therapy area that deals with diseases of the skin, hair and nails. Over 3,000 distinct dermatological conditions are thought to exist, ranging from rare a ...Read More
Jun 2017 $6995.00
Back to Report Store Home Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation
By GBI Research
Description Globally, liver cancer is the sixth most common cancer, but its poor prognosis makes it the second leading cause of cancer-related death (Globocan, 2012). Currently, the range of therapi ...Read More
Jun 2017 $6995.00
Back to Report Store Home Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation
By GBI Research
Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable auto-immune disease that affects the joints, and is characterized by synovial inflammation and hyperplasia. It occurs when a ...Read More
Aug 2016 $6995.00
Back to Report Store Home Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential
By GBI Research
Immunology is a large therapy area characterized by disorders of the immune system – specifically an aberrant immune response against healthy tissues present in the body, leading to chronic or a ...Read More
Jan 2017 $6995.00
Back to Report Store Home Global Immunology Drugs Market to 2022-Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth
By GBI Research
Immunology is a therapy area characterized by disorders of the immune system, specifically an aberrant autoimmune response against healthy tissues in the body, leading to chronic or acute inflammation ...Read More
May 2017 $4995.00
Back to Report Store Home Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline
By GBI Research
GBI Research’s latest report: “Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline” is a comprehensive, granular analysis of the 25,522 ...Read More
May 2017 $2995.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

Published By :  GlobalData

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z